Skip to main content

Table 2 The univariate analysis for recurrence in MTC patients

From: Ultrasound features of medullary thyroid cancer as predictors of biological behavior

Variable

N

Recurrence

P

No

Yes

Age (years)

 

49.5 ± 12.1

53.4 ± 9.3

0.266a

Preoperative Ct/tumor size (pg/mL/mm)

 

32.15

51.68

0.002b

Gender

   

0.768

 Female

38

31 (54.4)

7 (50.0)

 

 Male

33

26 (45.6)

7 (50.0)

 

Tumor size (cm)

 

1.48 ± 0.96

1.81 ± 1.11

0.271

  ≤ 1

30

26 (45.6)

4 (28.6)

0.247

 >1

41

31 (54.4)

10 (71.4)

 

Multifocality

   

0.917

 Yes

22

17 (29.8)

5 (35.7)

 

 No

49

40 (70.2)

9 (64.3)

 

Extrathyroid extension

   

0.047

 Yes

39

28 (49.1)

11 (78.6)

 

 No

32

29 (50.9)

3 (21.4)

 

Central node metastasisc

   

0.000

 Yes

30

18 (32.7)

12 (85.7)

 

 No

39

37 (67.3)

2 (14.3)

 

Lateral node metastasisd

   

1.000

 Yes

26

18 (78.3)

8 (72.7)

 

 No

8

5 (21.7)

3 (27.3)

 

T stage

   

0.166

 T1 + T2

32

28 (49.1)

4 (28.6)

 

 T3 + T4

39

29 (50.9)

10 (71.4)

 

N stage

   

0.003

 N0

33

32 (56.1)

1 (7.1)

 

 N1a

12

7 (12.3)

5 (35.7)

 

 N1b

26

18 (31.6)

8 (57.1)

 

Preoperative Ct level (pg/mL)

   

0.009

  ≤ 100

16

16 (28.1)

0 (0.0)

 

 100–1000

31

25 (43.9)

6 (42.9)

 

  > 1000

24

16 (28.1)

8 (57.1)

 

Biochemical curee

   

0.000

 Yes

39

37 (78.7)

2 (15.4)

 

 No

21

10 (21.3)

11 (84.6)

 

Classification of TI-RADS

   

0.013

  l-MTC

22

22 (38.6)

0 (0.0)

 

 m-MTC

49

35 (61.4)

14 (100.0)

 
  1. at test; b Mann-Whitney U test; c 2 patients underwent thyroidectomy without lymph node dissection; d Only 38 patients were performed lateral lymph node dissection; e Postoperative serum Ct is available in 63 cases,and 3 of these patients had underwented palliative surgery